Presently, over 65 companies claim to offer drug repurposing-related services to the global pharmaceutical industry
Repurposing of marketed / shelved / pipeline candidates for the treatment of diseases (different from original target indications) has emerged …
Read MoreThe gene therapy market is projected to be worth USD 14.6 billion in 2030, claims Roots Analysis
Driven by the potential to treat the root cause of diseases, including rare clinical conditions and those that were previously …
Read MoreHuman Microbiome-based Products Market is growing at an annualized rate of over 40%.
Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic products, …
Read MoreHuman Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030
Over the years, extensive R&D efforts have enabled microbiome-based therapy / diagnostic developers to make significant strides, in terms of …
Read MoreThe High Energy / Hazardous Chemistry-based API manufacturing services market is estimated to be worth USD 29 billion in 2030, predicts Roots Analysis
Although hazardous reaction chemistries are not used during early drug development stages owing to the associated risks, they offer a …
Read MoreThe contract fill / finish services market for biologics is anticipated to be worth USD 4.2 billion by 2030.
A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service …
Read More